Cargando…

A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect

Cancer Targeting Gene-Viro-Therapy (CTGVT) is a promising cancer therapeutical strategy that strengthens the anti-tumour effect of oncolytic virus by expressing inserted foreign anti-tumour genes. In this work, we constructed a novel adenoviral vector controlled by the tumour-specific survivin promo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xin-Ran, Cai, Ying, Cao, Xin, Wei, Rui-Cheng, Li, Hui-Ling, Zhou, Xiu-Mei, Zhang, Kang-Jian, Wu, Shuai, Qian, Qi-Jun, Cheng, Biao, Huang, Kun, Liu, Xin-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823082/ https://www.ncbi.nlm.nih.gov/pubmed/21794078 http://dx.doi.org/10.1111/j.1582-4934.2011.01396.x

Ejemplares similares

Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery
por: Wang, Y, et al.
Publicado: (2005)

Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
por: Saari, Heikki, et al.
Publicado: (2020)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells
por: Li, Wenjie, et al.
Publicado: (2020)

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer
por: Tazawa, Hiroshi, et al.
Publicado: (2017)

Targeted adenoviral vectors
por: Vigne, E, et al.
Publicado: (2001)

Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)

Xenogenic Adenoviral Vectors
por: Both, Gerald W.
Publicado: (2002)

Construction and Antiapoptosis Activities of Recombinant Adenoviral Expression Vector Carrying EBV Latent Membrane Protein 2A
por: Liu, Xishuang, et al.
Publicado: (2011)

Oncolytic viruses & their specific targeting to tumour cells
por: Singh, Prafull K., et al.
Publicado: (2012)

MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways
por: Cui, Shi-Yun, et al.
Publicado: (2014)

Brivanib in combination with Notch3 silencing shows potent activity in tumour models
por: Giovannini, Catia, et al.
Publicado: (2019)

Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth
por: Lefesvre, Pierre, et al.
Publicado: (2002)

ADENOVIRAL VECTORS FOR PROTEIN EXPRESSION
por: Von Seggern, Dan J., et al.
Publicado: (1999)

Construction and application of adenoviral vectors
por: Zhang, Hongbo, et al.
Publicado: (2023)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
por: Zhang, Qiwei, et al.
Publicado: (2022)

An oncolytic adenovirus 11p vector expressing adenovirus death protein in the E1 region showed significant apoptosis and tumour-killing ability in metastatic prostate cells
por: Wu, Haidong, et al.
Publicado: (2019)

A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
por: Zhang, L, et al.
Publicado: (2015)

Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Cheng, Jiqiu, et al.
Publicado: (2017)

Tumour-specific triple-regulated oncolytic herpes virus to target glioma
por: Delwar, Zahid M., et al.
Publicado: (2016)

SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment
por: Kong, Defeng, et al.
Publicado: (2022)

ING Proteins: Tumour Suppressors or Oncoproteins
por: Jacquet, Karine, et al.
Publicado: (2021)

Parking CAR T Cells in Tumours: Oncolytic Viruses as Valets or Vandals?
por: Evgin, Laura, et al.
Publicado: (2021)

Adenoviral Vectors for Hemophilia Gene Therapy
por: Brunetti-Pierri, N, et al.
Publicado: (2013)

The Role of Chromatin in Adenoviral Vector Function
por: Wong, Carmen M., et al.
Publicado: (2013)

Use of adenoviral vectors as veterinary vaccines
por: Ferreira, T B, et al.
Publicado: (2005)

Immunology of Adenoviral Vectors in Cancer Therapy
por: Shaw, Amanda Rosewell, et al.
Publicado: (2019)

Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016)

A novel adenoviral vector carrying an all-in-one Tet-On system with an autoregulatory loop for tight, inducible transgene expression
por: Chen, Hao, et al.
Publicado: (2015)

Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours.
por: Shi, Y. F., et al.
Publicado: (1996)

Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo
por: Streuli, Charles H
Publicado: (2002)

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients
por: Taipale, Kristian, et al.
Publicado: (2018)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma
por: Deng, Lili, et al.
Publicado: (2022)

Targeting of BMI-1 with PTC-209 shows potent anti-myeloma activity and impairs the tumour microenvironment
por: Bolomsky, Arnold, et al.
Publicado: (2016)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
por: Zhuo, Chuanjun, et al.
Publicado: (2019)

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Cheng, Jiqiu, et al.
Publicado: (2019)

Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors
por: Cheng, Jiqiu, et al.
Publicado: (2018)

Tumour suppressor genes in chemotherapeutic drug response
por: Lai, Dulcie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kg4bvc4em9qlheglqa2ohjhukt